Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Oseltamivir in Hospitalized Influenza
NCT01052961Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oseltamivir in influenza (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: rate of influenza virus load decline at 5 days and rate of viral RNA negativity at 5 days. Started Jan 2010; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01052961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052961.